Skip to Content

Lower Cognitive and Psychiatric Adverse Events During Adjunctive Cenobamate

Cenobamate may be a suitable treatment option for patients who experience cognitive or psychiatric treatment-emergent adverse events with their current ASMs. In this MEDtalk, William E. Rosenfeld, MD, part-time consultant and advisor at SK Life Science, USA, presents two studies of cenobamate treatment.

William E. Rosenfeld

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top